Trial End Points and Natural History in Patients With G11778A Leber Hereditary Optic Neuropathy : Preparation for Gene Therapy Clinical Trial

Overview of attention for article published in JAMA Ophthalmology, April 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

blogs: 1 blog
twitter: 3 X users

wikipedia: 4 Wikipedia pages

Readers on

mendeley: 61 Mendeley

So far, Altmetric has seen 5 X posts from 3 X users, with an upper bound of 22,535 followers.

@CaesarBiotech I need somebody to explain me why mean visual accuity is 15,9 letters (=1,3LogMAR) at 36 weeks post baseline (44 patients, Lam et al, https://t.co/ELJ4bQFtwz) when it is here > 1.8logMAR with #Gensight. Thanks in advance. $sight

@BiotechRadar Si cela vous intéresse, Il existe une étude très intéressante de 2014 qui compile des données historiques (qq années) de l'acuité visuelle et des paramètres physiques associés de patients LHON. https://t.co/LKQj2OzEBN

Trial End Points and Natural History in Patients With G11778A Leber Hereditary Optic Neuropathy Preparation for... http://t.co/X5ck74cMoY

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 1 additional X posts.